DelveInsight’s “Sturge-weber Syndrome (SWS) Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Sturge-weber Syndrome (SWS), historical and forecasted epidemiology as well as the Sturge-weber Syndrome (SWS) market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Sturge-Weber Syndrome Overview
Sturge–Weber syndrome, sometimes referred to as encephalotrigeminal angiomatosis, is a rare congenital neurological and skin disorder. It is one of the phakomatoses and is often associated with port-wine stains of the face, glaucoma, seizures, intellectual disability, and ipsilateral leptomeningeal angioma (cerebral malformations and tumors). Sturge–Weber syndrome can be classified into three different types, type 1, type 2, and type 3.
Sturge–Weber is an embryonal developmental anomaly resulting from errors in mesodermal and ectodermal development. Unlike other neurocutaneous disorders (phakomatoses), Sturge–Weber occurs sporadically (i.e., does not have a hereditary cause). It is caused by a mosaic, somatic activating mutation occurring in the GNAQ gene. Imaging findings may include tram track calcifications on pial angiomatosis and hemicerebral atrophy.
The Report Covers the Sturge-Weber Syndrome Epidemiology Segmented by –
-
Sturge-Weber Syndrome prevalent cases
-
Sturge-Weber Syndrome incident cases
-
Sturge-Weber Syndrome diagnosed cases
-
Sturge-Weber Syndrome treatment cases
Click here to learn more about the Sturge-Weber Syndrome Market Landscape
Sturge-Weber Syndrome Market Outlook
The Sturge-weber Syndrome market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Sturge-weber Syndrome market trends by analyzing the impact of current Sturge-weber Syndrome therapies on the market, unmet needs, drivers and barriers, and demand for better technology.
This segment gives a thorough detail of the Sturge-weber Syndrome market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Sturge-weber Syndrome market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the Sturge-weber Syndrome market in 7MM is expected to witness a major change in the study period 2019-2032.
Key Companies Working in the Sturge-Weber Syndrome Market include:
-
Qlaris Bio Inc
-
Jazz Pharmaceuticals
And many others
Sturge-Weber Syndrome Therapies Covered in the Report:
-
QLS
-
Cannabidiol
And many others
Learn more about Key Companies and Emerging Therapies in the Sturge-Weber Syndrome Market
Table of Contents
-
Key Insights
-
Report Introduction
-
Executive Summary of Sturge-Weber Syndrome Market
-
Sturge-Weber Syndrome Background and Overview
-
Sturge-Weber Syndrome Epidemiology and patient population
-
Sturge-Weber Syndrome Market Emerging Therapies
-
Sturge-Weber Syndrome Market Cancer Market Outlook
-
Market Access and Reimbursement of Therapies
-
Appendix
-
Market Report Methodology
-
DelveInsight Capabilities
-
Disclaimer
-
About DelveInsight
Learn more about detailed report offerings @ Sturge-Weber Syndrome Market Outlook
Related Reports
Sturge-Weber Syndrome Pipeline Insight
The “Sturge-Weber Syndrome – Pipeline Insight, 2023” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in the Sturge-Weber Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products by stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Trending Reports by DelveInsight
-
Adalimumab Biosimilar Market
-
Arbovirus Infection Market
-
Artificial Pancreas Device System Market
-
Dental Equipment Market
-
Gluten Sensitivity Market
-
Hypothyroidism Market
-
Inflammatory Bowel Disease Market
-
Mayus Kinase Jak Inhibitors Market
-
Mild Dry Eye Market
-
Mucopolysaccharidosis Market
-
Oncolytic Virus Cancer Therapy Market
-
Pyoderma Gangrenosum Market
-
Transdermal Drug Delivery Devices Market
-
Intrathecal Pumps Market
-
Hedgehog Pathway Inhibitors Market
-
Yellow Fever Market
-
Laryngeal Cancer Market
-
Female Infertility Market
-
Gender Dysphoria Market
-
Chronic Brain Damage Market
-
Spain Healthcare Outlook Market
-
Malignant Fibrous Histiocytoma Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services